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Pancreatic endocrine tumors (PET) are extremely rare,
accounting for less than 1% of all pancreatic neoplasms
and may present with a variety of clinical syndromes de-
pending on the presence and type of hormone production.1
Pancreatic endocrine tumors include insulinomas,
gastrinomas, VIPomas (tumors that secrete vasoactive in-
testinal peptide), glucagonomas, somatostatinomas, and
nonfunctioning pancreatic endocrine tumors. Insulinoma is
the most common PET, and gastrinoma is the second most
common; consequently, in most cases, PET produces
hypoglycemic or hypergastrinemic syndromes.1 The re-
maining PETs are very rare indeed.1 Thus, the presenta-
tion of these tumors with a clinical feature of diarrheogenic
syndrome is an exceedingly rare clinical entity. The clini-
cal features of VIPoma are a severe but intermittent
diarrhea, often of a watery nature. A true carcinoid tumor
of the pancreas accounts for less than 1% of gastrointestinal
carcinoids2–9 and generally has a poor prognosis.8–11 The
most frequent symptoms found in patients with pancreatic
carcinoids are abdominal pain and diarrhea.5,8–11
Although the term carcinoid is well established in medi-
cal terminology, it is no longer adequate to cover the en-
tire morphological and biological spectrum of neoplasms
of the disseminated neuroendocrine cell system. Therefore,
the WHO classification published in 2000 uses instead the
general terms, neuroendocrine tumor and neuroendocrine
carcinoma. Although the pancreas is an uncommon loca-
tion for a carcinoid tumor, the complex cell population of
the pancreas may give rise to a large group of endocrine
tumors with pluripotential secretory capabilities.2 Pancre-
atic carcinoids originate from the enterochromaffin cells
(Kultschitsky cells) that are usually present in the exocrine
glands of the pancreatic tissue and in the pancreatic islet
cells, which retain the capacity to secrete serotonergic de-
rivatives, 6,7,12 carcinoids also originate from multipotent
stem cells of the duct epithelium that may differentiate into
any one of a variety of adult endocrine-secreting cells,
mainly into monoamine and/or various peptide hormone-
producing cells.4,13 It is apparent that the endocrine com-
ponent cells of the pancreas consist not only of the cells
of the islets of Langerhans, but also of endocrine cells in
its ducts and acini.14
When compared with carcinoids in other sites, the pan-
creatic carcinoid has specific features: (i) the lowest inci-
dence; (ii) argyrophil stain is more likely to be positive than
argentaffin; (iii) tendency to be the largest; and (iiii) high-
est incidence of metastases and carcinoid syndrome, result-
ing in the most unfavorable prognosis.8
The objective of this report was to describe an addi-
tional case of carcinoid tumor of the pancreas with a clini-
cal feature of diarrheogenic syndrome, adding to those pre-
viously reported, and to review the world literature in an
attempt to define the clinical presentation, morphologic
findings, treatment, and prognosis of this unusual tumor.
CASE REPORT
A 62-year-old white woman was admitted to the
Servidor Público State Hospital because of 3 to 6 evacua-
tions per day of pasty or liquid feces with onset 2 years
previously and without the presence of blood. She denied
having abdominal pain or weight loss. Physical exam did
not show significant alterations. The 24-hour fecal fat ex-
cretion, amylasemia, potassium, fasting glycemia, and se-
rum values of carcinoembryonic antigen (CEA) and CA 19-
9 were normal. Abdominal sonography revealed the pres-
ence of a retroperitoneal solid mass. Computerized tom-
ography (CT) and magnetic resonance of the abdomen
showed a solid and irregular mass located in the cephalic
area of the pancreas, proximal to the inferior vena cava
(Fig. 1). Phlebography of the inferior vena cava, performed
via the femoral vein, did not reveal signs of invasion. Ex-
ploratory laparotomy detected a hardened mass in the ce-
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phalic portion of the pancreas, with an irregular surface,
measuring 12 x 8 cm in its largest diameter, that was
squeezed and stretched to the 1st and 2nd portions of the
duodenum (Fig. 2). The liver exhibited a normal and con-
sistent aspect, and the remaining areas of the abdominal
cavity did not present alterations. The pancreatic lesion was
extirpated by partial pancreatoduodenectomy (Whipple’s
operation). Anatomopathological exam of the surgical
specimen revealed a pancreatic carcinoid tumor with
angiolymphatic invasion that infiltrated the Vater’s ampulla
and the duodenal wall (Fig. 3). The lymph nodes, in a to-
tal of 15 structures, and the margins of the lesion were free
from neoplastic involvement. Immunohistochemical stud-
ies were performed on paraffin sections using commercially
available primary antibodies directed against a set of neu-
roendocrine antigens as well as different polypeptides. The
neoplasia exhibited reactivity to neuron-specific enolase
(NSE), EMA, CEA, factor VIII, serotonin (Fig. 4), gluca-
gon, and somatostatin, and was not reactive to PS100,
vimentin, cytokeratins AE1/AE3, or insulin. In the post-
operative period, the patient developed venous thrombosis
of the lower limbs, without other complications, and was
discharged on postoperative day 15. She remains well, with-
out symptoms, 5 years after the operation.
Although the histogenesis of carcinoid tumors of the
pancreas has yet to be fully clarified, embryologic studies
have demonstrated that argentaffin cells are present
throughout the foregut and migrate to the bronchioles, pan-
creatic ducts, and Langerhans islets.7,8 Wilson et al14 dem-
onstrated immmunoreactivity to enterochromaffin cells in
Figure 3 - Micrograph of a histological section of the pancreatic tumor
showing monomorphic tumor cells growing in an organoid pattern
characterized by nests, sheets, and ribbons. The tumor cells are small, round
to oval, with nuclei showing “salt and pepper” chromatin and with prominent
granular eosinophilic cytoplasm. The histological pattern is consistent with
a carcinoid tumor (hematoxilin & eosin staining; original magnification,
X200)
Figure 1 - Computed tomography of the abdomen with a solid mass (large
arrow) in the area at the level of the head of the pancreas, showing the
proximity between the mass and the inferior vena cava (small arrow)
Figure 2 - Resected product of partial gastroduodenopancreatectomy
(Whipple’s procedure) with a well-circumscribed nodular mass in the head
of the pancreas (arrow)
Figure 4 - Immunohistochemistry of the pancreatic tumor showing
serotonin-positive expression in neoplastic cells (immunoperoxidase, X400)
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islet cell tumors, and in non-neoplastic ducts and ductule,
acini and Langerhans islets. It has been suggested that the
islet cell and argentaffin cell are derived from the same neu-
roectodermal precursor or from the same multipotential pre-
cursor cells of the ductal epithelium, with the capacity to
proliferate and differentiate themselves from peptide or
monoamine hormone-producing cells.7,8
Carcinoid tumors are immunohistochemically positive
for the pan-endocrine markers, neuron-specific enolase and
chromogranin A, and also for antiserotonin antibodies,
which are considered specific markers for such tumors.3,4,8,9
When immunohistochemical techniques are positive for
serotonin in the tumor cells, the tumor can be classified as
a carcinoid tumor.3,7 In the present case, the immunohisto-
chemical study of the neoplastic tissue exhibited reactiv-
ity to serotonin, but also to glucagon and somatostatin,
among others. This fact suggests that the tumor probably
originated from pancreatic islet cells. As summarized by
Mao et al,8 several carcinoids of the pancreas have stained
positively for other islet cell hormones.
Pancreatic neuroendocrine tumors are extremely rare in
children, but occur in all age groups and in males and fe-
males with equal frequency,1 and they can occur in all parts
of the pancreas.1 Pancreatic carcinoids, because of their lo-
cation, tend to produce relatively vague, nonspecific symp-
toms resulting in larger, more advanced tumors at presen-
tation.5,8,9
Less than 10% of carcinoids present diarrhea caused by
systemic serotonin release. The explanation lies in the ef-
ficient hepatic metabolism of vasoactive amines, and that
is also the reason why carcinoid syndrome rarely occurs
in the absence of liver metastasis. Exceptions are circum-
stances in which venous blood from a large tumor was
drained directly into systemic circulation11 as may have
occurred in the present case.
The diarrhea associated with pancreatic carcinoids is
generally a consequence of pancreatic exocrine insuffi-
ciency and or intestinal action of serotonin produced by the
neoplasia.3,8,15 One might speculate that perhaps different
mediators produce diarrheas of different intensities.15 Stud-
ies of the possible role of vasoactive intestinal polypeptide
(VIP), prostaglandin E, and serotonin in the cause of the
watery diarrhea syndrome have attracted more attention.
Machado et al16 described a patient with a Verner-Morrison
diarrheogenic syndrome with a high plasma concentration
of VIP due to a neuroendocrine tumor located in the body
and tail of the pancreas and multiple liver metastases. The
diarrheogenic syndrome was controlled by surgical resec-
tion of the pancreatic neoplasm and postoperative hepatic
artery embolization.
In our patient, the diarrhea was intermittent and of lesser
severity than that found in VIPomas. Unfortunately, serum
values for the potential mediators of humoral diarrhea are
not available. Nonetheless, the results from the immuno-
histochemical studies were positive for serotonin, suggest-
ing that it might be involved in causing the diarrhea syn-
drome.
Jaundice is an unusual finding in pancreatic carcinoids,
as explained by the tumor location in the pancreatic body
and tail in 70% of patients and the slow and late infiltra-
tive growth.5,8,9 Although the lesion of the present case was
situated at the head of the pancreas and presented large di-
mensions, there was no clinical or laboratory jaundice,
probably due to the noninfiltrative nature of the pancreatic
mass.
Foregut carcinoids, similarly to pancreatic carcinoids,
tend to produce an atypical carcinoid syndrome11 with in-
creases in 5-hydroxytryptophan plasma levels, but usually
not serotonin plasma levels because they lack the appro-
priate decarboxylase.5 Nevertheless, urinary 5-hydroxy-in-
dole-acetic acid (5-HIAA) levels are markedly increased
in functioning pancreatic carcinoids, suggesting a 5-
hydroxytryptophan decarboxylation in the intestine and
other tissues.8
From a radiological point of view, the pancreatic car-
cinoid tumor may be indistinguishable from pancreatic is-
let cell tumors, as they have some common features.16
Echography of pancreatic carcinoid reveals the presence of
round or oval tumors that are generally well-defined and
hypoechoic in contrast to the normal neighboring pancre-
atic tissue. A hyperechoic capsule may be delimited by the
gland itself or may protrude from its surface. CT exami-
nation may detect well-circumscribed, homogeneous,
hypodense areas that may contain calcification. Following
administration of intravenous contrast material, there is a
marked enhancement of the tumor, as opposed to the pan-
creatic ductal carcinoma.17 Angiography of the celiac axis
and superior mesenteric artery may confirm the diagnosis
of an endocrine tumor by its marked vascularization and
may help to distinguish invasion from displacement of ad-
jacent large vessels.5 Fine-needle aspiration biopsy with
cytological examination and immunohistochemical tech-
niques may evidence serotonin or other hormones in tumor
cells and thereby enable a diagnosis of a carcinoid or a neu-
roendocrine pancreatic tumor.5
Although bulky tumors are frequently resectable as a
curative measure, the high incidence of distant metastases
precludes long-term survival for most patients, leading to
an unfavorable overall prognosis.5,8-10 Pancreatic carcinoids
present with a more advanced stage than other foregut
carcinoids, and outcomes are less favorable than for patients
with gastric and duodenal tumors.9 However, when there
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is no metastatic disease, surgical excision offers the best
chance for recovery or long-term survival.5,8,9
The high incidence of metastases described in pancre-
atic carcinoids probably results from the late onset of clini-
cal symptoms and the consequent late diagnosis, thereby
allowing sufficient time for metastasis of the tumor.5,8,9
Thus, tumor stage tends to be significantly more advanced
in pancreatic carcinoids, with a very strong negative im-
pact on outcome; hence it may be said that pancreatic
carcinoids are not necessarily more aggressive than other
carcinoids.9 Additionally, tumor diameter does not corre-
spond with the presence or absence of metastases.5
In cases with hepatic metastatic lesions, partial hepatic
resection or intra-arterial embolization of the metastatic
nodules has been attempted.18 For symptomatic treatment
of inoperable tumors, subcutaneous injection of
somatostatin-like substances or the administration of sero-
tonin or histamine antagonists have been used in addition
to supportive chemotherapy with streptozotocin and 5-fluor-
ouracil.18
Recognition of carcinoid tumors of the pancreas is im-
portant, since this type of tumor has better a prognosis than
the adenocarcinomas if detected early; additionally, effec-
tive treatment is available to combat the distressing symp-
toms due to the carcinoid syndrome. Accordingly, the re-
ports of cases of primary pancreatic carcinoid should sup-
port the differential diagnosis of diarrheogenic syndrome
and provide new insight into the biology of carcinoid
tumors and the mechanisms of their secretagogue action
in the release of amines and peptides.
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